References
1. Stern JH, Rutkowski JM, Scherer PE. Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell metabolism.2016;23(5):770-784.
2. Abou-Samra M, Selvais CM, Dubuisson N, Brichard SM. Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills… or Everything Together? International Journal of Molecular Sciences.2020;21(7):2620.
3. Achari AE, Jain SK. Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction.International journal of molecular sciences. 2017;18(6):1321.
4. Ferrarezi DA, Cheurfa N, Reis AF, Fumeron F, Velho G. Adiponectin gene and cardiovascular risk in type 2 diabetic patients: a review of evidences. Arquivos Brasileiros de Endocrinologia & Metabologia. 2007;51(2):153-159.
5. Travier N, Buckland G, Vendrell JJ, et al. Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors. European journal of cancer care.2018;27(4):e12861.
6. Laughlin GA, Barrett-Connor E, May S, Langenberg C. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. American journal of epidemiology. 2006;165(2):164-174.
7. La Cava A. Leptin in inflammation and autoimmunity. Cytokine. 2017;98:51-58.
8. Denroche HC, Huynh FK, Kieffer TJ. The role of leptin in glucose homeostasis. Journal of diabetes investigation. 2012;3(2):115-129.
9. Ahima RS. Revisiting leptin’s role in obesity and weight loss. The Journal of clinical investigation. 2008;118(7):2380-2383.
10. Jheng HF, Hirotsuka M, Goto T, Shibata M, Matsumura Y, Kawada T. Dietary low‐fat soy milk powder retards diabetic nephropathy progression via inhibition of renal fibrosis and renal inflammation. Molecular nutrition & food research. 2017;61(3):1600461.
11. González-Montoya M, Hernández-Ledesma B, Silván JM, Mora-Escobedo R, Martínez-Villaluenga C. Peptides derived from in vitro gastrointestinal digestion of germinated soybean proteins inhibit human colon cancer cells proliferation and inflammation. Food chemistry. 2018;242:75-82.
12. Peng Y, Shi Y, Zhang H, Mine Y, Tsao R. Anti-inflammatory and anti-oxidative activities of daidzein and its sulfonic acid ester derivatives. Journal of Functional Foods.2017;35:635-640.
13. Meng H, Fu G, Shen J, et al. Ameliorative effect of daidzein on cisplatin-induced nephrotoxicity in mice via modulation of inflammation, oxidative stress, and cell death.Oxidative medicine and cellular longevity. 2017;2017.
14. Holmdahl R, Sareila O, Olsson LM, Bäckdahl L, Wing K. Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation. Immunological reviews.2016;269(1):228-247.
15. Charles C, Yuskavage J, Carlson O, et al. Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause (New York, NY). 2009;16(2):395.
16. Llaneza P, González C, Fernandez-Iñarrea J, et al. Soy isoflavones, diet and physical exercise modify serum cytokines in healthy obese postmenopausal women.Phytomedicine. 2011;18(4):245-250.
17. Ma L, Grann K, Li M, Jiang Z. A pilot study to evaluate the effect of soy isolate protein on the serum lipid profile and other potential cardiovascular risk markers in moderately hypercholesterolemic Chinese adults. Ecology of food and nutrition. 2011;50(6):473-485.
18. Zemel MB, Sun X, Sobhani T, Wilson B. Effects of dairy compared with soy on oxidative and inflammatory stress in overweight and obese subjects. The American journal of clinical nutrition. 2010;91(1):16-22.
19. Vargas ML, Almario RU, Buchan W, Kim K, Karakas SE. Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome. Metabolism. 2011;60(12):1711-1718.
20. Maskarinec G, Steude JS, Franke AA, Cooney RV. Inflammatory markers in a 2-year soy intervention among premenopausal women. Journal of Inflammation. 2009;6(1):9.
21. Napora JK, Short RG, Muller DC, et al. High‐dose isoflavones do not improve metabolic and inflammatory parameters in androgen‐deprived men with prostate cancer. Journal of andrology. 2011;32(1):40-48.
22. Takahira M, Noda K, Fukushima M, et al. Randomized, double-blind, controlled, comparative trial of formula food containing soy protein vs. milk protein in visceral fat obesity. Circulation Journal. 2011;75(9):2235-2243.
23. Riesco E, Choquette S, Audet M, Lebon J, Tessier D, Dionne IJ. Effect of exercise training combined with phytoestrogens on adipokines and C-reactive protein in postmenopausal women: a randomized trial. Metabolism. 2012;61(2):273-280.
24. Rebholz C, Reynolds K, Wofford M, et al. Effect of soybean protein on novel cardiovascular disease risk factors: a randomized controlled trial. European journal of clinical nutrition. 2013;67(1):58-63.
25. Nadadur M, Stanczyk FZ, Tseng C-C, Kim L, Wu AH. The effect of reduced dietary fat and soy supplementation on circulating adipocytokines in postmenopausal women: a randomized controlled 2-month trial. Nutrition and cancer.2016;68(4):554-559.
26. Deibert P, Lazaro A, Schaffner D, et al. Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis. World Journal of Gastroenterology. 2019;25(9):1116.
27. Llanos AA, Peng J, Pennell ML, et al. Effects of tomato and soy on serum adipokine concentrations in postmenopausal women at increased breast cancer risk: a cross-over dietary intervention trial. The Journal of Clinical Endocrinology & Metabolism. 2014;99(2):625-632.
28. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Annals of internal medicine.2009;151(4):W-65-W-94.
29. Fedorov S. GetData Graph Digitizer version 2.24. Available at www getdata-graph-digitizer com. 2002;541:542.
30. Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj. 2011;343:d5928.
31. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS medicine. 2009;6(7):e1000100.
32. Borenstein M, Hedges LV, Higgins JP, Rothstein HR. Introduction to meta-analysis. John Wiley & Sons; 2011.
33. Tobias A. Assessing the influence of a single study in the meta-anyalysis estimate. Stata Technical Bulletin. 1999;8(47).
34. Christie DR, Grant J, Darnell BE, Chapman VR, Gastaldelli A, Sites CK. Metabolic effects of soy supplementation in postmenopausal Caucasian and African American women: a randomized, placebo-controlled trial. American journal of obstetrics and gynecology. 2010;203(2):153. e151-153. e159.
35. König D, Deibert P, Frey I, Landmann U, Berg A. Effect of meal replacement on metabolic risk factors in overweight and obese subjects. Annals of Nutrition and Metabolism. 2008;52(1):74-78.
36. Wu AH, Stanczyk FZ, Martinez C, et al. A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. The American journal of clinical nutrition. 2005;81(5):1133-1141.
37. Llaneza P, Gonzalez C, Fernández-Iñarrea J, Alonso A, Diaz F, Pérez-López FR. Soy isoflavones improve insulin sensitivity without changing serum leptin among postmenopausal women. Climacteric. 2012;15(6):611-620.
38. Lozovoy MAB, Bahls LD, Morimoto HK, Matsuo T, Dichi I. Blood pressure decrease with ingestion of a soya product (kinako) or fish oil in women with the metabolic syndrome: role of adiponectin and nitric oxide. British journal of nutrition.2012;108(8):1435-1442.
39. Deibert P, Solleder F, König D, et al. Soy protein based supplementation supports metabolic effects of resistance training in previously untrained middle aged males. The Aging Male. 2011;14(4):273-279.
40. Rebholz CM, Friedman EE, Powers LJ, Arroyave WD, He J, Kelly TN. Dietary protein intake and blood pressure: a meta-analysis of randomized controlled trials.American journal of epidemiology. 2012;176(suppl_7):S27-S43.
41. Reynolds K, Chin A, Lees KA, Nguyen A, Bujnowski D, He J. A meta-analysis of the effect of soy protein supplementation on serum lipids. The American journal of cardiology. 2006;98(5):633-640.
42. Yun JE, Sull JW, Lee HY, et al. Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients. Diabetes/metabolism research and reviews.2009;25(3):259-265.
43. Imerbtham T, Thitiwuthikiat P, Jongjitwimol J, Nuamchit T, Yingchoncharoen T, Siriwittayawan D. Leptin Levels are Associated with Subclinical Cardiac Dysfunction in Obese Adolescents. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020;13:925.
44. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends in Endocrinology & Metabolism. 2000;11(8):327-332.
45. Triantafyllou GA, Paschou SA, Mantzoros CS. Leptin and hormones: energy homeostasis.Endocrinology and Metabolism Clinics. 2016;45(3):633-645.
46. Perez-Suarez I, Ponce-González JG, de La Calle-Herrero J, et al. Severe energy deficit upregulates leptin receptors, leptin signaling, and PTP1B in human skeletal muscle.Journal of Applied Physiology. 2017;123(5):1276-1287.
47. Cnop M, Havel PJ, Utzschneider K, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46(4):459-469.
48. Nishizawa H, Shimomura I, Kishida K, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002;51(9):2734-2741.
49. Haun CT, Mobley CB, Vann CG, et al. Soy protein supplementation is not androgenic or estrogenic in college-aged men when combined with resistance exercise training.Scientific reports. 2018;8(1):1-13.
50. Gavrila A, Chan JL, Yiannakouris N, et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. The Journal of Clinical Endocrinology & Metabolism. 2003;88(10):4823-4831.
51. Sieminska L, Wojciechowska C, Niedziolka D, et al. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels. Metabolism.2005;54(12):1610-1614.
52. Casabiell X, Pineiro V, Peino R, et al. Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: dexamethasone and estradiol stimulate leptin release in women, but not in men. The Journal of clinical endocrinology and metabolism. 1998;83(6):2149-2155.
53. Zhang R, Liao E, Wu X, et al. Concentration of serum leptin and age in Chinese women and comparison with other races. Zhong nan da xue xue bao Yi xue ban= Journal of Central South University Medical sciences. 2009;34(11):1136-1141.
54. Yanagisawa M, Sugiya M, Iijima H, Nakagome I, Hirono S, Tsuda T. Genistein and daidzein, typical soy isoflavones, inhibit TNF‐α‐mediated downregulation of adiponectin expression via different mechanisms in 3 T 3‐L 1 adipocytes.Molecular nutrition & food research. 2012;56(12):1783-1793.
55. Zhang H-M, Chen S-W, Zhang L-S, Feng X-F. The effects of soy isoflavone on insulin sensitivity and adipocytokines in insulin resistant rats administered with high-fat diet. Natural product research. 2008;22(18):1637-1649.